SAB Biotherapeutics Inc

NASDAQ:SABS 2:19:10 PM EDT

4.46

-0.14 (-3.04%)

4:00:29 PM EDT: $4.41 -0.05 (-1.12%)

SAB Biotherapeutics Inc Stock, NASDAQ:SABS

2100 East 54th Street North, Suite 202, Sioux Falls, South Dakota 57104

United States of America

Phone: +1.605.679.6980

Number of Employees: 57

http://www.sab.bio

Description

SAB Biotherapeutics, Inc. is a clinical-stage, biopharmaceutical company. It is engaged in advancing a new class of immunotherapies leveraging fully-human polyclonal antibodies. The firm produces human polyclonal immunotherapies and its versatile DiversitAb platform is applicable for unmet needs in human diseases. SAB Biotherapeutics was founded by Eddie J. Sullivan and Christine E. Hamilton in July 2014 and is headquartered in Sioux Falls, SD.